Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.
about
Designing cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell bindingEmerging mass spectrometry-based approaches to probe protein-receptor interactions: focus on overcoming physiological barriersTransferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometryEngineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersEvaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery.Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions.Pharmacokinetics of recombinant bifunctional fusion proteins.Poly(amino carbonate urethane)-based biodegradable, temperature and pH-sensitive injectable hydrogels for sustained human growth hormone delivery.Engineering of therapeutic proteins production in Escherichia coli.Strategies for non-invasive delivery of biologics.Fusion protein linkers: property, design and functionality.The oral delivery of peptides and proteins: established versus recently patented approaches.Orally active-targeted drug delivery systems for proteins and peptides.Post-production protein stability: trouble beyond the cell factory.Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells.Recent advances in oral delivery of peptide hormones.Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells.Chemically modified peptides and proteins - critical considerations for oral delivery.Nanostructure controlled sustained delivery of human growth hormone using injectable, biodegradable, pH/temperature responsive nanobiohybrid hydrogel.Periplasmic production via the pET expression system of soluble, bioactive human growth hormone.Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.Effect of flexible linker length on the activity of fusion protein 4-coumaroyl-CoA ligase::stilbene synthase.High-level production of animal-free recombinant transferrin from Saccharomyces cerevisiae.The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a LigandEnhanced delivery of human growth hormone across cell membrane by Tat-PTD.Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli.Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogelStudies on lactoferrin nanoparticles of gambogic acid for oral delivery.Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.Development of a P((MAA-co-NVP)-g-EG) Hydrogel Platform for Oral Protein Delivery: Effects of Hydrogel Composition on Environmental Response and Protein Partitioning.Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins
P2860
Q28252009-5BEA6B28-25C8-459B-88A9-7AC701FE74C4Q34691652-E3B4A9CF-4AF2-4711-96A0-D84A437BA7CFQ35511065-F3B2AA86-2337-436E-ACEC-E54B2418561AQ35571088-48DD19F3-5302-4CD9-BC40-88F745343C8CQ35636332-523BF967-FC42-4AA4-879C-DB893A570C37Q35782785-410A0021-DF22-4250-8BA6-6B330D68F4CAQ36187435-A82D09E1-6551-4B28-9F5F-386C2B519D60Q36342738-94D6978E-5586-42A5-980E-20ED50326B54Q37033032-71AE9B44-7D22-48A1-B687-316F9D10B7AEQ37110930-F26D9AAF-C8D0-41B5-879F-B0251D6B3391Q37807056-F480EB99-7B9F-493E-8E59-57E567DA5F02Q38013190-F48200B8-DA9C-41F3-85D6-6E11FAFF6755Q38048516-D11E8D93-EAA8-4244-B412-44C570973B5AQ38162959-2064CFB1-268F-48AB-AE42-5FF013BF94BFQ38223053-F40FB74B-7F54-40E0-BD23-532CB283D9A1Q38264351-F8614FB0-25C4-4DB1-85D1-1414E96E27B6Q38286395-5967A96C-1427-40F2-A64F-05A80022CAB5Q38703514-F3978E4E-9573-470D-9575-46F92ECB38B7Q38746305-9B085DBB-ED6E-47E6-B464-30CEBDD37817Q38881431-D72A745E-E1E0-4279-A7C5-90623591F53CQ38918349-A05B19F9-B351-4BB5-B71F-C736AF3BDF94Q39241703-87C1A222-D831-4CD7-9E97-E6075610ADB3Q39682781-9262575A-B689-4B0B-B520-3A50D2C589AAQ40442426-A8DD10FB-7D40-482C-B4D4-630FAE1BA2D4Q41127405-D46B91C8-BFD0-4029-9308-0C7B609D5285Q41843707-3F56CB49-4478-4AB0-8C52-6E6E58FB7570Q42272124-872F68F6-F01B-4955-9D78-E61F5EC36117Q42572918-D416B3DC-30DD-4FC5-99F4-3A106FFFA055Q43103872-11E14349-FAF0-4679-AB5F-211591B71CD5Q43499161-E4EDB3E5-D334-44A5-BE83-491BBD9151D1Q45330895-312163D1-6F0B-4B2F-90FC-DE4D3CFBCBA8Q47577583-1A5D1D55-2B44-463C-B28F-648297207A34Q47776048-E6CDC08D-638F-4408-B809-207EB1D9EDD8Q48159203-99F9AEC6-7968-438D-AC54-59F59C6DE058Q50227956-B30AE849-660C-4DDF-93F5-AFF3D778FCFDQ57369611-DA4E96B9-0963-4485-96E4-8240D6D68DB0
P2860
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@ast
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@en
type
label
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@ast
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@en
prefLabel
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@ast
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@en
P2093
P2860
P1476
Human growth hormone-transferr ...... ery in hypophysectomized rats.
@en
P2093
Nurmamet Amet
Wei-Chiang Shen
P2860
P304
P356
10.1016/J.JCONREL.2009.09.007
P407
P577
2009-09-15T00:00:00Z